Latest Insights - page 30 | BiopharmaTrend

Pusan National University Researchers Develop AI Model to Identify Therapeutic Gene Targets Using Hypergraphs

A team from Pusan National University, led by Associate Professor Giltae Song, has developed a new artificial intelligence model called the Hypergraph Interaction Transformer (HIT) to improve the identification of …

Continue ›››

Lokavant Releases AI-Based Forecasting Tool for Clinical Trial Enrollment

Lokavant has launched Spectrum v15, an AI-powered clinical trial forecasting platform designed to reduce uncertainty in feasibility planning and enrollment timelines. Built on a historical dataset covering over 500,000 clinical …

Continue ›››

BlackfinBio Receives FDA Clearance to Begin Clinical Trial for Gene Therapy in Rare Childhood Motor Disorder

BlackfinBio, a UK-based gene therapy company, has received FDA clearance to begin a Phase 1/2 trial of its AAV-based candidate BFB-101 for Hereditary Spastic Paraplegia Type 47 (SPG47), a rare …

Continue ›››

Real-World Study Reports 91% of Tinnitus Patients Improved With Neuromod's FDA-Approved Device

A real-world study published in Nature Communications Medicine has reported that 91.5 percent of tinnitus patients experienced a clinically meaningful reduction in symptoms after 12 weeks of treatment using Lenire, …

Continue ›››

NeoGenomics Adopts Ultima Genomics Platform to Expand Sequencing-Based Oncology Diagnostics

NeoGenomics has partnered with Ultima Genomics to integrate the UG 100 sequencing platform into its Cambridge, UK innovation center, aiming to develop a new range of clinical oncology tests. The …

Continue ›››

Molecular Devices Launches Automated System for Microbial Colony Picking

Molecular Devices has introduced the QPix FLEX Microbial Colony Picking System, a compact, automated platform for microbial colony screening. The system is designed to replace manual picking workflows with automated …

Continue ›››

Atropos Health Adds Ontada Oncology Data to Expand Community Cancer Coverage in Real-World Evidence Network

Atropos Health has integrated data from Ontada, a McKesson company focused on community oncology, into the Atropos Evidence Network. The collaboration adds Ontada’s proprietary iKnowMed oncology dataset, sourced in part …

Continue ›››

Deep Genomics Releases AI Foundation Model for microRNA Binding and mRNA Degradation Prediction

Deep Genomics has introduced REPRESS, a deep learning model trained to predict microRNA (miRNA) binding and mRNA degradation directly from nucleotide sequence—two core mechanisms that determine mRNA stability and influence …

Continue ›››

Datavant to Acquire Aetion, Expanding Into End-to-End Real-World Evidence Analytics for Life Sciences

Datavant has announced its acquisition of Aetion, a real-world evidence (RWE) platform used by regulators and biopharma companies to assess drug effectiveness and safety. The combined platform is expected to …

Continue ›››

Dementia Discovery Fund Closes Second Fund at $269M, Bringing Total Raised to Over $550M

The Dementia Discovery Fund (DDF), managed by SV Health Investors, has closed its second fund, DDF-2, at $269 million, bringing total capital raised across its funds to over $550 million. …

Continue ›››

NIH BRAIN Initiative Backs Toolkit of 1,000+ Enhancer AAVs for Cell-Type Targeting in Brain Disorders

A consortium of researchers led by the Allen Institute, with collaborators from over two dozen U.S. institutions including Harvard, Broad, Duke, and Stanford, has released more than 1,000 enhancer AAV …

Continue ›››

Phesi Analyzes 167M Patient Records, Finds Colorectal Cancer Has Largest Oncology RWD Volume

Phesi has released a new analysis based on 167 million patient records processed via its Trial Accelerator platform, highlighting substantial disparities in real-world data (RWD) availability and trial efficiency in …

Continue ›››